English
This article is from Radiotherapy and Oncology , volume 110 . Abstract Background and purpose: A substantial reduction of uncertainties in clinical brachytherapy should result in improved outcome in terms of increased local control and reduced side effects. Types of uncertainties have to be identified, grouped, and quantified. Methods: A detailed literature review was performed to identify uncertainty components and their relative importance to the combined overall uncertainty. Results: Very few components (e.g., source strength and afterloader timer) are independent of clinical disease site and location of administered dose. While the influence of medium on dose calculation can be substantial for low energy sources or non-deeply seated implants, the influence of medium is of minor importance for high-energy sources in the pelvic region. The level of uncertainties due to target, organ, applicator, and/or source movement in relation to the geometry assumed for treatment planning is highly dependent on fractionation and the level of image guided adaptive treatment. Most studies to date report the results in a manner that allows no direct reproduction and further comparison with other
Sign in with your free account to read, download EPUBs or listen.
Ebook · Review of clinical brachytherapy uncertainties: Analysis guidelines of GEC-ESTRO and the AAPM☆. · Kirisits, Christian, Rivard, Mark J., Baltas, Dimos, Ballester, Facundo, De Brabandere, Marisol, van der Laarse, Rob, Niatsetski, Yury, Papagiannis, Panagiotis · Internet Archive